JDQ443, a potent and selective, orally bioavailable covalent inhibitor of GDP-bound KRASG12C with an IC50 of 0.012 ?M for inhibition of c-Raf recruitment.
[1] Weiss A, et al. Cancer Discov. 2022 Jun 2;12(6):1500-1517.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥1,554.00 | 现货 | 1 | |
| 5mg | ¥3,420.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥3,958.00 | 现货 | 1 |
















JDQ443, a potent and selective, orally bioavailable covalent inhibitor of GDP-bound KRASG12C with an IC50 of 0.012 ?M for inhibition of c-Raf recruitment.
[1] Weiss A, et al. Cancer Discov. 2022 Jun 2;12(6):1500-1517.